Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

191
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
191
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

200
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
200

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Real-world use and impact of direct oral anticoagulants among atrial fibrillation patients with cardioembolic stroke.

Frontiers in neurology·2026
Same author

Gender-Specific Trends and Determinants of Daily Smoking in Latvia (2009-2019): A Population-Based Cross-Sectional Study.

Medicina (Kaunas, Lithuania)·2026
Same author

Evolocumab in Patients With Prior Percutaneous Coronary Intervention and No Prior Myocardial Infarction: Results From the VESALIUS-CV Trial.

Circulation·2026
Same author

Pitfalls in the reporting of clinical events in unblinded device trials: analysing performance bias in the BIO|GUARD-MI trial.

Trials·2026
Same author

Quality of Life After Percutaneous Coronary Intervention or Medical Therapy for Chronic Total Coronary Occlusions: EUROCTO and DECISION-CTO Meta-Analysis.

Journal of the American College of Cardiology·2026
Same author

Percutaneous coronary intervention versus coronary artery bypass grafting for unprotected left main stenosis: 10-year final results from the randomised, open-label, non-inferiority NOBLE trial.

Lancet (London, England)·2026

相关实验视频

Updated: Jan 1, 2026

Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery ALCAPA
13:10

Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery ALCAPA

Published on: April 24, 2017

19.1K

穿皮冠状动脉血管整形与冠状动脉旁路移植在未受保护的左主狭窄症的治疗中:随机,非劣势NOBLE试验的最新5年结果

Niels R Holm1, Timo Mäkikallio2, M Mitchell Lindsay3

  • 1Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark.

Lancet (London, England)
|December 28, 2019
PubMed
概括

五年后的结果显示,冠状动脉旁路移植 (CABG) 优于穿皮冠状动脉干预 (PCI) 治疗左主冠状动脉疾病. 在主要心脏不良事件,心肌梗塞和重复血管化方面,CABG显示出更好的结果.

更多相关视频

Author Spotlight: Enhancing Coronary Artery Revascularization
05:25

Author Spotlight: Enhancing Coronary Artery Revascularization

Published on: September 15, 2023

1.1K
Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
09:12

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery

Published on: March 27, 2018

9.8K

相关实验视频

Last Updated: Jan 1, 2026

Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery ALCAPA
13:10

Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery ALCAPA

Published on: April 24, 2017

19.1K
Author Spotlight: Enhancing Coronary Artery Revascularization
05:25

Author Spotlight: Enhancing Coronary Artery Revascularization

Published on: September 15, 2023

1.1K
Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
09:12

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery

Published on: March 27, 2018

9.8K

科学领域:

  • 心血管医学
  • 干预心脏病学
  • 临床试验

背景情况:

  • 穿皮冠状动脉干预 (PCI) 越来越多地被采用用于左主冠状动脉疾病 (LMACD) 的重血管化,挑战传统的冠状动脉旁路移植 (CABG).
  • NOBLE试验最初评估了PCI与CABG在LMACD治疗中的不劣势.
  • 本分析提供了NOBLE试验的最新5年结果.

研究的目的:

  • 在患有左主冠状动脉疾病的患者中,评估PCI与CABG的5年临床结果.
  • 为了确定PCI是否与CABG相比,在5年的随访中,主要的心脏或脑血管不良事件 (MACCE) 是不劣的.
  • 在PCI和CABG组之间比较二次终点,包括全因死亡率,心肌梗塞和重复血管化.

主要方法:

  • 一个前性,随机的,开放的,非劣势性试验 (NOBLE) 涉及1201名LMACD患者.
  • 患者被分配到PCI或CABG (1:1比例).
  • 主要终点是MACCE (所有原因死亡率,非程序性心脏病发作,重复血管化,中风),非劣势性被定义为1. 35的危险率上限.

主要成果:

  • 在平均4. 9年的随访期内,MACCE发生在28%的PCI患者和19%的CABG患者中 (HR1. 58;95%CI为1. 24-2.
  • 所有原因的死亡率相似 (9%对9%,HR为1. 08).
  • 与CABG相比,PCI显示非手术性心肌梗塞 (8%与3%相比;HR 2. 99;p=0.0002) 和重复血管化 (17%与10%相比;HR 1.73;p=0.0009) 的发生率显著提高.

结论:

  • 与CABG相比,PCI在5年内与左主冠状动脉疾病重血管化的较差临床结果有关.
  • 虽然死亡率相似,但PCI治疗导致心肌梗塞和重复血管化的发生率增加.
  • 基于这些5年发现,CABG仍然是LMACD的优越再血管化策略.